Journal Club Seminars
|Seminars were organized by: Dr. Shou-En Lu
||Room 3A, (3rd FL)
683 Hoes Lane
||1:30 PM to 2:30 PM
Weichung Joe Shih, Ph.D.
Bridging Clinical Trials - What Are They?
Weili He, Ph.D.
A Model-Based Approach in the Estimation of the Maximum Tolerated Dose in Phase I Cancer Clinical Trials
Jason Liao, Ph.D.
Breaking Root N Barrier in Monte Carlo Integration
Shou-En Lu, Ph.D.
Case-Cohort Design and Analysis for Clustered Failure Time Data
Andre Rogatko, Ph.D.
Fox Chase Cancer Center
Patient Specific Dosing in Phase I Clinical Trials: The Role of EWOC
Gordon Lan, Ph.D.
Select the Winner in Drug Development
Pei-Ling Chu, Ph.D. Student
Model-Based Designs for Phase I Cancer Clinical Trials
Pamela Ohman-Strickland, Ph.D.
Data Reduction using Growth Models in Protein Folding Prediction - Work in Progress
Peiling Chu, Ph.D. Cadidate
Title: Model-Based Designs for Phase I Cancer Clinical Trials
Location:CINJ, Room 5546
Time: 10:00 am on Wednesday, May 19, 2004
Yong Lin , Ph.D.
Statistical Properties of Modified Algorithm-Based Designs
for Phase I Cancer Clinical Trials
Jason Liao , Ph.D.
Logistic Regression when the number of predictors is larger then the number of subjects: Application to microarray data
Shou-En Lu, Ph.D.
Modeling the association between PM2.5 and Emergency Room Visit in NJ
Susan Huyck, M.S.
Statistician, Schering-Plough Research Institute, and Ph.D. student, UMDNJ
Method Validation in the Pharmaceutical Industry - One Approach
Dirk Moore, Ph.D.
Repeated Measures Modeling of the Mouse Hippocampus in Recombinant Inbred Strains
Yen-Hong Kuo, MS
Jersey Shore Medical Center
Issues in Assessing Statistical Associations in Medical Research
This week's seminar is at a different time, 1:00 PM - 2:00 PM
Daniel Zelterman, Ph.D.
Epidemiology and Public Health, Yale University
Statistical Inference in Familial Disease Clusters
Joanna H. Shih, Ph.D.
Biometric Research Branch, Division of Cancer Treatment and Diagnosis
National Cancer Institute
Estimating Relative Risk, Cumulative Risk and Familial Aggregation From Case-Control Designs With Genotype and Family History Data